Genzyme UK HomeGenzyme Corporate HomeSearchContact UsGenzyme Websites
Company InfoOur Treatement AreasHealthcare Professionals
Genzyme

Our Therapies and Products
Gaucher Disease
Fabry Disease
MPS I
Pompe Disease
Thyroid Cancer
Renal Disease
Joint Diseases and Injuries
Abdominal Surgery
Diagnostic Products

About MPS I

MPS I (also known as Hurler, Hurler-Scheie, and Scheie Syndromes) is an inherited lysosomal storage disorder caused by the deficiency of an enzyme called alpha-L-iduronidase.

This enzyme is required for the breakdown of certain substances in the body known as glycosaminoglycans (commonly referred to as GAGs). Glycosaminoglycans are complex substances produced by the body that are found in all types of connective tissue. Connective tissue provides structural support to organs and tissues and makes up the cartilage of growing bones, joints, and heart valves. Without sufficient quantities of this enzyme, GAGs accumulate in virtually all organs of the body causing progressive disease.

The incidence of MPS I is estimated at about 1 in 100,000 births.

Even though many patients with this disease may have the same enzyme deficiency, patients with this disease can have a wide range of symptoms and experience variable degrees of disease severity.

Signs and Symptoms

Below is a list of common symptoms of MPS I:

Frequent ear and lung infections

Slow growth

Upper airway obstruction and reduced pulmonary function

Enlarged liver and spleen

Joint deformities and reduced range of motion

Sleep apnoea (temporary cessation of breathing during sleep)

Malaise and reduced endurance

Delay and regression of mental development

Impaired vision and hearing

Impaired cardiovascular and heart function

Diagnosis

Before a diagnosis is made, patients may see several specialists since some of the early signs and symptoms of MPS I are commonly seen in many children. As MPS I is a rare disease, physicians may not consider MPS I as a diagnosis.

There are two methods your physician can use to diagnose MPS I. One of the first steps is to look for abnormally high levels of glycosaminoglycans (GAGs) in a urine sample. A definitive diagnosis of MPS I is established by testing the level of enzyme activity in a blood or skin sample.

Family Screening

MPS I is an inherited disorder, and therefore family screening is extremely important. One diagnosis of MPS I may uncover other affected siblings within a family. With early diagnosis, the disease may be better managed.




CONTACT INFORMATION:

Genzyme Therapeutics Ltd,
Genzyme Biosurgery

4620 Kingsgate
Cascade Way
Oxford Business Park South
Oxford
OX4 2SU
Tel: 01865 405200
Fax: 01865 774172

Genzyme Therapeutics Ltd
Genzyme Europe Research

310 Cambridge Science Park
Milton Road
Cambridge
CB4 0WG
Tel: 01223 394000
Fax: 01223 394190

Genzyme Ltd
Genzyme Diagnostics

50 Gibson Drive
Kings Hill
West Malling
Kent
ME19 4AF
Tel: 01732 220022
Fax: 01732 220024

Genzyme Ltd
Haverhill Operations

12 Rookwood Way
Haverhill
Suffolk
CB9 8PB
Tel: 01440 703522
Fax: 01440 716269

Registered Office for Genzyme Therapeutics Ltd
4620 Kingsgate
Cascade Way
Oxford Business Park South
Oxford
OX4 2SU
Company Registration No. 4316333
Registered in England

Registered Office for Genzyme Ltd
37 Hollands Road
Haverhill
Suffolk
CB9 8PU
Company Registration No. 01556886 Registered in England

Terms and Conditions of Use | Privacy Policy | © 2003-2008 Genzyme Corporation. All rights reserved.